Genovis provides enzymes and technologies for analytical characterization and conjugation of biopharmaceuticals.

The industry transition from small molecule drugs to large biopharmaceuticals require new tools for analytical workflows and detailed characterization of complex drugs such as monoclonal antibodies, antibody drug conjugates, Fc-fusion proteins etc. The SmartEnzymes developed and provided by Genovis are widely used throughout the biopharmaceutical industry to study critical drug quality attributes.